Riskpilot← Back to searchSign inGet full accessAegirBio Sweden AB
ABActiveOrg 5591672869Scheelevägen 27Research and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2023
SEK 0
EBITDA margin
—
+99% vs 2022
Equity ratio
60.9%
Financial strength
Net profit 2023
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -376K | +99% |
| Net profit | SEK 0 | — |
| Total assets | SEK 4,3M | -2% |
| Equity | SEK 2,6M | +0% |
| Employees | 0 | — |
Legal name
AegirBio Sweden AB
Org number
5591672869
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3 augusti 2018
Share capital
SEK 69 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Uppgift om firmateckning saknas Styrelsen ska bestå av 2 styrelseledamöter och 1 styrelsesuppleant. Registrerad behörig styrelse saknas. Därför saknas också uppgift om firmateckningsrätten. Registrerad kvalificerad revisor saknas.
Company purpose
Aktiebolaget ska utveckla och kommersialisera biosensorer för medicinskt bruk.
Address
Scheelevägen 27
Email
info@thyrolytics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 506 | 218 | 10 459 | 1 393 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 8 | −1 431 | −18 923 | −25 843 | −376 |
| Depreciation & amort. | −0 | −0 | −3 323 | −0 | −0 |
| EBIT | 8 | −1 431 | −22 246 | −25 843 | −376 |
| Net financials | — | — | — | 226 | 3 |
| Profit before tax | 7 | −1 431 | 0 | 0 | 0 |
| Tax | −7 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −1 431 | 0 | 0 | 0 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 027 | 3 473 | 34 618 | 4 397 | 4 303 |
| Equity | 1 882 | 2 621 | 2 621 | 2 621 | 2 621 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 144 | 851 | 31 997 | 1 775 | 1 681 |
| Total debt | 144 | 851 | 31 997 | 1 775 | 1 681 |
EBITDA margin
-37600000.0%
This company
15.8%
Market median
-237974784% vs market
20192023
Equity ratio
60.9%
This company
38.2%
Market median
+59% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-08-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
LJ Chief Auditor | Chief Auditor | 2022 – 2023 |
MT Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
AF | Audit | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (11) | ||
| Deputy Board Member | 2020 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2020 | |
| Chairman | 2022 – 2025 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Aegirbio AB
AegirBio Sweden AB Board members of AegirBio Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Johan Rasmusson | Chief Auditor | 0 companies |
| Mohamad Takwa | Chief Executive Officer | 0 companies |
| Anders Filip Lundberg | Audit | 0 companies |
| Jan Lars Fredrik Häglund | Deputy Board Member | 0 companies |
| Nils Johan Peter Paulsson | Board of Directors | 0 companies |
| Elias Set Jenö Arnér | Board of Directors | 0 companies |
| Sylvie Elisabeth Bove | Board of Directors | 0 companies |
| Per Johan Anders Källstrand | Deputy Board Member | 0 companies |
| Marco Daniel Jan Durk Witteveen | Chairman | 0 companies |
| Sven Martin Linde | Chairman | 0 companies |
| Vasiliki Fragkou | Board of Directors | 0 companies |
| Stefan Hugo Kylebäck | Board of Directors | 0 companies |
| Robert Porter | Board of Directors | 0 companies |
| Per Lennart Stefan Åkesson | Board of Directors | 0 companies |
| Jens Patrik Elfwing | Chairman | 0 companies |